Healthcare >> CEO Interviews >> December 5, 2001
DANIEL GLASSMAN, a registered pharmacist, founded Bradley
Pharmaceuticals, Inc., in January 1985, and was the key force that took
the company public as a NASDAQ traded corporation in November 1991. He
has guided Bradley since its inception, serving as Chairman of the
Board, Chief Executive Officer, and President. Mr. Glassman also is
Chairman of the Board, President and Chief Executive Officer of Doak,
Bradley Pharmaceuticals (Canada), Inc., and Bradley Pharmaceuticals,
Overseas, Ltd., Inc., each a subsidiary of Bradley Pharmaceuticals, Inc.
He has been awarded the Ernst & Young LLP Entrepreneur of the Year in
the New Jersey Life Sciences division. Profile
the past couple of quarters?
Mr. Glassman: The accelerated positive financial trends that started in
about the second
